A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Summary

The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

Timeline

Start

2025-10-03

Primary completion

2028-09-19

Completion

2032-10-06

Drugs

Indications